What is she best known for?
The fields of study she is best known for:
- Cancer
- Immune system
- Internal medicine
Lisa H. Butterfield spends much of her time researching Immunology, Immune system, Immunotherapy, Antigen and Internal medicine.
The Immunology study combines topics in areas such as Cancer, Melanoma and Hepatocellular carcinoma.
As part of one scientific family, she deals mainly with the area of Immune system, narrowing it down to issues related to the Epitope, and often Antigen presentation and MHC class I.
Her Antigen research includes themes of Interleukin, Antibody, Glioma and Antigen-presenting cell.
Her research on Internal medicine also deals with topics like
- Oncology and related Vaccination,
- Surgery which is related to area like Pembrolizumab.
Her studies deal with areas such as Molecular biology and Cell culture as well as T cell.
Her most cited work include:
- Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. (413 citations)
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial (368 citations)
- B cells and tertiary lymphoid structures promote immunotherapy response (330 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Immunology, Immunotherapy, Immune system, Antigen and Cancer.
Her Immunology research incorporates elements of Cytotoxic T cell, Internal medicine and Oncology.
Her work in the fields of Immunotherapy, such as Cancer immunotherapy, intersects with other areas such as Biomarker discovery.
She focuses mostly in the field of Immune system, narrowing it down to topics relating to Cancer research and, in certain cases, Cell.
Lisa H. Butterfield usually deals with Antigen and limits it to topics linked to Antigen-presenting cell and Interleukin 12.
Many of her research projects under Cancer are closely connected to Context with Context, tying the diverse disciplines of science together.
She most often published in these fields:
- Immunology (52.40%)
- Immunotherapy (34.80%)
- Immune system (32.80%)
What were the highlights of her more recent work (between 2015-2021)?
- Immunotherapy (34.80%)
- Immunology (52.40%)
- Immune system (32.80%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunotherapy, Immunology, Immune system, Cancer and Internal medicine.
Her Immunotherapy research focuses on Cancer immunotherapy in particular.
Her research in Immunology intersects with topics in Melanoma and Glioma.
Her work carried out in the field of Immune system brings together such families of science as Cancer research, Cell therapy and Peptide vaccine.
Her Internal medicine study combines topics from a wide range of disciplines, such as Oncology and Sarcoma.
Lisa H. Butterfield works mostly in the field of Antigen, limiting it down to topics relating to Vaccination and, in certain cases, Vaccine therapy.
Between 2015 and 2021, her most popular works were:
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial (368 citations)
- B cells and tertiary lymphoid structures promote immunotherapy response (330 citations)
- Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade. (140 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Internal medicine
Her scientific interests lie mostly in Immunology, Cancer, Immunotherapy, Internal medicine and Immune system.
Her work on Immunology is being expanded to include thematically relevant topics such as Melanoma.
Her Cancer research includes elements of Microbiome, Human biology and Evasion.
Her studies in Immunotherapy integrate themes in fields like Tumor Cell Biology, Clinical trial, Head and neck squamous-cell carcinoma, Head and neck cancer and Alternative medicine.
Her Internal medicine research is multidisciplinary, relying on both Undifferentiated Pleomorphic Sarcoma, Oncology, Leiomyosarcoma and Synovial sarcoma.
Her Immune system research includes themes of Cognitive science and Biomarker.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
